During the pandemic, physicians used infusions of monoclonal antibodies to help patients fight off COVID-19 infections. Now, in response to the U.S. opioid crisis, researchers at UC Davis are trying to create monoclonal antibodies that can help fight chronic pain. The research is funded by a $1.5 million grant from the National Institutes of Health's HEAL Initiative.
Learn more about this research: [ Ссылка ]
See the latest news from UC Davis Health: [ Ссылка ]
#opioid #opioidcrisis #monoclonalantibodies #research #ucdavis
